while in life science, it seeks to support biopharmaceutical companies in China with breakthrough technologies in areas like ...

Scientific discovery requires its own foundational technology and our life sciences customers' success with complex ... Prior to joining Alexion in 2015, George was employed by Merck & Co., Inc. for ...

Caris Life Sciences has obtained an FDA approval for its MI Cancer ... Finally, the assay can be used with Merck’s Keytruda ...

Ginkgo provides update on its restructuring process including an acceleration of site consolidation initiatives and continued progress on cost reductions Ginkgo signs ...

Vietnam Expands for 2025 with Addition of New Hall - The largest edition yet, nearly double the size of the 2023 edition. - ...

In 2024, we established a license and research collaboration with MSD (tradename of Merck & Co., Inc., Rahway ... We are supported by leading life science investors SV Health Investors, Johnson & ...

CONN Bertish’s recent South African Seriaaas!! Mental Resilience Project supported over 2 million South Africans with more ...

In 2024, we established a license and research collaboration with MSD (tradename of Merck & Co., Inc., Rahway ... We are supported by leading life science investors SV Health Investors, Johnson & ...

KOMET phase III trial of Koselugo shows statistically significant and clinically meaningful ORR vs. placebo in adults with neurofibromatosis type 1: Cambridge, UK Wednesday, Novem ...

The Cas nuclease market is on an upward trajectory, forecasted to grow from $2.75 billion in 2023 to $3.27 billion in 2024, at a CAGR of 18.9%. Key drivers include the rapid advancements in genome ...